You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Adjuvant chemotherapy for advanced endometrial cancer
|
|---|---|
| Published in |
Cochrane database of systematic reviews, May 2014
|
| DOI | 10.1002/14651858.cd010681.pub2 |
| Pubmed ID | |
| Authors |
Khadra Galaal, Mansour Al Moundhri, Andrew Bryant, Alberto D Lopes, Theresa A Lawrie |
| Abstract |
Approximately 13% of women diagnosed with endometrial cancer present with advanced stage disease (International Federation of Gynecology and Obstetrics (FIGO) stage III/IV). The standard treatment of advanced endometrial cancer consists of cytoreductive surgery followed by radiation therapy, or chemotherapy, or both. There is currently little agreement about which adjuvant treatment is the safest and most effective. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 40% |
| Unknown | 3 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 80% |
| Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 214 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 212 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 28 | 13% |
| Other | 21 | 10% |
| Student > Master | 20 | 9% |
| Student > Doctoral Student | 20 | 9% |
| Student > Ph. D. Student | 15 | 7% |
| Other | 42 | 20% |
| Unknown | 68 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 92 | 43% |
| Nursing and Health Professions | 16 | 7% |
| Biochemistry, Genetics and Molecular Biology | 12 | 6% |
| Agricultural and Biological Sciences | 4 | 2% |
| Computer Science | 3 | 1% |
| Other | 17 | 8% |
| Unknown | 70 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2023.
All research outputs
#4,388,494
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,676
of 11,499 outputs
Outputs of similar age
#40,910
of 241,637 outputs
Outputs of similar age from Cochrane database of systematic reviews
#137
of 220 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,637 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 220 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.